Morgan Stanley Institutional Fund Quote
| MAIHX Fund | USD 15.73 0.02 0.13% |
Performance0 of 100
| Odds Of DistressLess than 22
|
Morgan Stanley is trading at 15.73 as of the 9th of January 2025; that is 0.13% increase since the beginning of the trading day. The fund's open price was 15.71. Morgan Stanley has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of January 2023 and ending today, the 9th of January 2025. Click here to learn more.
Under normal circumstances, the fund invests at least 80 percent of its net assets in the equity securities of issuers located outside of the United States. This policy may be changed without shareholder approval however, the investors would be notified upon 60 days notice in writing of any changes.. More on Morgan Stanley Institutional
Moving together with Morgan Mutual Fund
Moving against Morgan Mutual Fund
Morgan Mutual Fund Highlights
| Fund Concentration | Morgan Stanley Funds, Large Blend Funds, Foreign Large Blend Funds, Foreign Large Blend, Morgan Stanley (View all Sectors) |
| Update Date | 31st of December 2024 |
Morgan Stanley Institutional [MAIHX] is traded in USA and was established 9th of January 2025. Morgan Stanley is listed under Morgan Stanley category by Fama And French industry classification. The fund is listed under Foreign Large Blend category and is part of Morgan Stanley family. This fund now has accumulated 143.61 M in assets with no minimum investment requirementsMorgan Stanley Insti is currently producing year-to-date (YTD) return of 0.64% with the current yeild of 0.02%, while the total return for the last 3 years was -1.74%.
Check Morgan Stanley Probability Of Bankruptcy
Instrument Allocation
Sector Allocation
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Morgan Mutual Fund. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Morgan Mutual Fund, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Morgan Stanley Institutional Mutual Fund, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.
Top Morgan Stanley Institutional Mutual Fund Constituents
| BBCA | JPMorgan BetaBuilders Canada | Etf | Miscellaneous Region | |
| AIR | AAR Corp | Stock | Industrials | |
| AMS | American Shared Hospital | Stock | Health Care | |
| BABA | Alibaba Group Holding | Stock | Consumer Discretionary | |
| MU | Micron Technology | Stock | Information Technology | |
| NEM | Newmont Goldcorp Corp | Stock | Materials | |
| NVO | Novo Nordisk AS | Stock | Health Care |
Morgan Stanley Insti Risk Profiles
| Mean Deviation | 0.6167 | |||
| Standard Deviation | 0.879 | |||
| Variance | 0.7726 | |||
| Risk Adjusted Performance | (0.11) |
Morgan Stanley Against Markets
Other Information on Investing in Morgan Mutual Fund
Morgan Stanley financial ratios help investors to determine whether Morgan Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Morgan with respect to the benefits of owning Morgan Stanley security.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |